InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
VTX
7.89%
20.5¢
VERTEX MINERALS LIMITED - Charts / Financials
Market Cap $22.11M
!
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 15.40pm 15/11/2024 (20 minute delay)
?
Day | ||||||||
---|---|---|---|---|---|---|---|---|
Open | 19.0¢ | Day High | 20.5¢ | Day Low | 19.0¢ | |||
Daily Volume | 203264 |
Bids | Sellers | |||||
---|---|---|---|---|---|---|
Number | Price | Volume | Number | Price | Volume | |
1 | 20.5¢ | 4377 | 4 | 21.0¢ | 95578 |
Data source: Refinitiv